KUKJE PHARMA CO., LTD. Toevoegen aan een lijst
|
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 4.745 KRW | +0,74% |
|
-1,86% | -19,85% |
Totale waarde
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 74.643 | 81.078 | 176.865 | 112.861 | 106.115 | 119.890 |
| Bedrijfswaarde 1 | 96.777 | 106.601 | 210.728 | 140.944 | 129.152 | 139.920 |
| K/w-verhouding | 33,4 x | -17 x | 80,3 x | -72,2 x | 29,9 x | -14,2 x |
| Dividendrendement | 0,7% | - | - | - | - | - |
| Marktkapitalisatie/omzet | 0,69 x | 0,73 x | 1,36 x | 0,94 x | 0,84 x | 0,89 x |
| Bedrijfswaarde/omzet | 0,9 x | 0,96 x | 1,62 x | 1,18 x | 1,02 x | 1,03 x |
| Bedrijfswaarde/EBITDA | 16,1 x | 12,1 x | 21,8 x | 51,4 x | 13,2 x | 63,2 x |
| Bedrijfswaarde/FCF | 11,6 x | 29,2 x | -51,3 x | 25,7 x | 36,9 x | 16,4 x |
| FCF Yield | 8,6% | 3,42% | -1,95% | 3,89% | 2,71% | 6,11% |
| Price to Book | 1,07 x | 1,33 x | 2,51 x | 1,65 x | 1,43 x | 1,41 x |
| Aantal aandelen (in duizenden) | 20.236 | 20.272 | 20.272 | 20.265 | 20.258 | 20.252 |
| Referentieprijs 2 | 3.689 | 4.000 | 8.725 | 5.569 | 5.238 | 5.920 |
| Datum van publicatie | 13/03/19 | 10/03/20 | 17/03/21 | 10/03/22 | 16/03/23 | 18/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Omzet 1 | 107.681 | 111.122 | 130.395 | 119.746 | 126.583 | 135.373 |
| EBITDA 1 | 6.028 | 8.813 | 9.667 | 2.743 | 9.760 | 2.215 |
| Bedrijfsresultaat (EBIT) 1 | 3.287 | 5.562 | 6.041 | -1.676 | 5.273 | -1.989 |
| Operationele Marge | 3,05% | 5,01% | 4,63% | -1,4% | 4,17% | -1,47% |
| Resultaat voor belastingen (EBT) 1 | 2.830 | 121,4 | 5.594 | -1.110 | 4.745 | -6.681 |
| Nettowinst (verlies) 1 | 2.193 | -4.761 | 2.203 | -1.559 | 3.557 | -8.415 |
| Nettomarge | 2,04% | -4,28% | 1,69% | -1,3% | 2,81% | -6,22% |
| WPA 2 | 110,3 | -235,0 | 108,7 | -77,10 | 175,2 | -415,5 |
| Free Cash Flow 1 | 8.323 | 3.645 | -4.106 | 5.485 | 3.504 | 8.550 |
| FCF-marge | 7,73% | 3,28% | -3,15% | 4,58% | 2,77% | 6,32% |
| Kasstroomconversie (ebitda) | 138,08% | 41,36% | - | 199,94% | 35,9% | 386,02% |
| Kasstroomconversie (nettowinst) | 379,59% | - | - | - | 98,5% | - |
| Dividend per aandeel 2 | 25,92 | - | - | - | - | - |
| Datum van publicatie | 13/03/19 | 10/03/20 | 17/03/21 | 10/03/22 | 16/03/23 | 18/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 22.135 | 25.523 | 33.862 | 28.084 | 23.037 | 20.030 |
| Nettokaspositie 1 | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 3,672 x | 2,896 x | 3,503 x | 10,24 x | 2,36 x | 9,043 x |
| Free Cash Flow 1 | 8.323 | 3.645 | -4.106 | 5.485 | 3.504 | 8.550 |
| ROE (netto-inkomsten/eigen vermogen) | 3,2% | -7,35% | 3,34% | -2,24% | 4,97% | -10,6% |
| ROA (netto-inkomsten/totale activa) | 1,59% | 2,67% | 2,69% | -0,73% | 2,38% | -0,83% |
| Totale activa 1 | 137.624 | -178.612 | 81.747 | 212.445 | 149.179 | 1.014.856 |
| Nettoactief per aandeel 2 | 3.455 | 3.006 | 3.477 | 3.384 | 3.656 | 4.194 |
| Cashflow per aandeel 2 | 184,0 | 367,0 | 198,0 | 388,0 | 273,0 | 523,0 |
| Capex 1 | 3.026 | 5.887 | 11.600 | 1.892 | 1.259 | 1.046 |
| Capex/omzet | 2,81% | 5,3% | 8,9% | 1,58% | 0,99% | 0,77% |
| Datum van publicatie | 13/03/19 | 10/03/20 | 17/03/21 | 10/03/22 | 16/03/23 | 18/03/24 |
1KRW in Miljoen2KRW
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Historische marktkapitalisatie/EBITDA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -19,85% | 69,49 mln. | |
| +15,91% | 41,97 mld. | |
| +22,40% | 22,34 mld. | |
| +18,48% | 15,25 mld. | |
| +16,12% | 14 mld. | |
| +45,12% | 12,06 mld. | |
| -9,58% | 6,8 mld. | |
| -0,05% | 6,79 mld. | |
| -8,87% | 5,73 mld. | |
| +14,18% | 5,49 mld. |
- Beurs
- Aandelen
- Koers A002720
- Financiën Kukje Pharma Co., Ltd.
